Skip Links

 

About us

We are a leading generic pharmaceutical company with a significant presence in the Middle East and North Africa (”MENA”) region, the United States and Europe.

Currently, we sell 369 pharmaceutical products in 767 dosage strengths and forms in 49 countries. 40 of our products are sold under promotion and distribution agreements with, or licenses from, 16 originator pharmaceutical companies and three generic pharmaceutical companies.

Share price

19 Mar 2010

606.0p (+4.48%)